KOSDAQChemicals101670

Hydro Lithium

₩219 0.00%2026-11-18 close
Market Cap
₩12.4B
Turnover
₩0
Volume
0 shares
Shares out.
56.8M
PER
—
PBR
0.6×
EPS
-₩712
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Losses Persist; Geumsan Lawsuit and Cash Are Key Variables

Hydro Lithium swung to an operating loss of KRW 15.1 billion in 2025 and has posted losses in five consecutive quarters through the third quarter of 2026, with the Geumsan plant lawsuit and thin cash seen as the main hurdles to normalization.

  1. 1

    Revenue peaked at KRW 22.9 billion in 2023, then fell to KRW 8.47 billion in 2024 and KRW 3.37 billion in 2025, declining for two consecutive years from 2024 through 2025.

  2. 2

    Net loss attributable to controlling shareholders was KRW 34.7 billion in 2025, and losses have run for four consecutive years from 2022 through 2025.

  3. 3

    Over the last four quarters, from Q4 2025 to Q3 2026, net loss attributable to controlling shareholders totaled KRW 40.1 billion, and Q1 2026 alone recorded KRW 34.2 billion after the prior quarter's profit.

  4. 4

    In the Geumsan plant lawsuit with the counterparty Lithium Forth, the first-instance court fully upheld the claim around April 2026, ordering cancellation of the ownership transfer registration and delivery of movable assets.

  5. 5

    Standalone cash equivalents were reported in the KRW 200 million range at the end of Q1 2026, while the fixed assets subject to revaluation carry a combined book value of KRW 29.7 billion.

02

Business structure

Hydro Lithium was founded in 1995 and began manufacturing and selling lithium products for secondary batteries after a 2022 acquisition by a related company, which led to its renaming. Its main products are lithium hydroxide and lithium carbonate, including battery-grade lithium products.

A business analysis compiled by JobKorea as of March 2026 shows that lithium hydroxide and lithium carbonate account for most of its revenue.

Its core production base is the Geumsan plant in South Chungcheong Province, which produces lithium hydroxide monohydrate, anhydrous lithium hydroxide and lithium carbonate, with designed capacity of about 3,600 tons. The Geumsan plant was designated as part of the Geumsan lithium general industrial complex in 2025.

The company attributes the revenue decline to the exclusion of its former construction business during the shift to batteries. The Saemangeum lithium plant is viewed as a new growth engine, but uncertainty over when construction will resume led to a KRW 19.7 billion impairment loss.

The company said it signed a binding Head of Agreement with a North American lithium resource developer, Prairie Lithium, covering lithium intermediate supply and commercial production from a Canadian salt lake, and plans to produce and sell lithium carbonate using its CULX technology.

Press reports, however, describe the project as being at a very early stage.

The lithium refining market faces large capacity expansions led mainly by Chinese producers and ongoing price competition, and whether its process technology and product competitiveness can differentiate it in the market will be a key variable over the medium to long term.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩700M-₩3B−460.8%
2025Q4₩600M-₩4.6B−796.9%
2026Q1₩1B-₩3.4B−353.8%
2026Q2₩1.1B-₩3.4B−323.2%
2026Q3₩500M-₩2.3B−512.3%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩11.5B-₩3.8B-₩3.4B−33.2%−6.2%154.5%
2023₩22.9B-₩35.8B-₩40.6B−156.7%−58.8%48.2%
2024₩8.5B₩9.1B-₩17.7B108.0%−21.1%12.6%
2025₩3.4B-₩15.1B-₩34.7B−447.1%−55.6%31.3%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-14

04

Earnings analysis

Annual results show shrinking revenue and deepening losses at the same time.

Revenue rose from KRW 11.5 billion in 2022 to KRW 22.9 billion in 2023, a 99.1% increase, then fell to KRW 8.47 billion in 2024, down 63.0%, and to KRW 3.37 billion in 2025, down 60.2%. 2023 was the largest year and 2025 the smallest among 2022 to 2025.

Operating losses were KRW 3.81 billion in 2022 and KRW 35.8 billion in 2023, before the company returned to an operating profit of KRW 9.15 billion in 2024 and then swung back to an operating loss of KRW 15.1 billion in 2025. Operating margins were -156.7% in 2023, 108.0% in 2024 and -447.1% in 2025.

Net loss attributable to controlling shareholders was KRW 3.39 billion in 2022, KRW 40.6 billion in 2023, KRW 17.7 billion in 2024 and KRW 34.7 billion in 2025, which means four consecutive years of losses.

Net loss including non-controlling interests was KRW 34.7 billion in 2025, the same size as the loss attributable to controlling shareholders.

The company cited lower lithium prices, reduced volume and higher fixed costs during the early stage of its business transition as causes of the 2025 operating loss, and said asset impairments that increased non-operating expenses added to the net loss.

Operating cash flow was negative in all four years, at KRW -9.02 billion in 2022, KRW -12.6 billion in 2023, KRW -3.17 billion in 2024 and KRW -10.2 billion in 2025.

Total equity at the end of 2025 was KRW 62.4 billion, all attributable to controlling shareholders, against total liabilities of KRW 19.5 billion, and the debt ratio fell from 154.5% in 2022 to 31.3% in 2025.

Quarterly results moved from revenue of KRW 661 million and an operating loss of KRW 3.04 billion in Q3 2025 to revenue of KRW 576 million and an operating loss of KRW 4.59 billion in Q4 2025, while Q4 2025 still recorded a net profit attributable to controlling shareholders of KRW 695 million.

Revenue in Q1 2026 rose 65.3% from the prior quarter to KRW 952 million, but the operating loss was KRW 3.37 billion and the net loss attributable to controlling shareholders reached KRW 34.2 billion.

Q2 2026 showed revenue of KRW 1.07 billion, an operating loss of KRW 3.45 billion and a net loss attributable to controlling shareholders of KRW 4.05 billion.

Q3 2026 revenue was KRW 452 million, down 31.6% year on year, with an operating loss of KRW 2.32 billion, which narrowed from a year earlier, and a net loss attributable to controlling shareholders of KRW 2.57 billion, which widened from a year earlier.

Losses have run for five consecutive quarters from Q3 2025 through Q3 2026, and for three consecutive quarters from Q1 2026 through Q3 2026.

05

Industry analysis

Lithium prices fell close to 90% from their peak before recovering more than twofold from the trough on expanding energy storage demand and supply adjustments. A July 2026 press report noted that prices remain more than 70% below the peak.

Weak lithium demand has been prolonged, and profitability recovery for lithium refiners has been slow. Large capacity expansions led mainly by Chinese producers have kept pricing pressure in place.

With 2025 revenue of KRW 3.37 billion and Q3 2026 revenue of KRW 452 million, Hydro Lithium is small in this market, so its ability to absorb raw material and product price swings is limited. Its business is concentrated in a single lithium product line, so price movements pass directly into results.

The Saemangeum plant and overseas salt lake projects could add capacity, but both are at an early stage. Its medium-term competitiveness depends on whether its process technology and product differentiation gain recognition in the market.

As of mid-2026, the key industry checkpoint is the pace of demand recovery rather than whether prices have bottomed.

06

Outlook

The company's stated plans cover operations at the Geumsan plant and lithium carbonate production, resumption of construction at the Saemangeum plant, and supply discussions for a North American salt lake project.

The Geumsan plant's operating base has been shaken by the first-instance loss in the ownership dispute, and the outcome of subsequent proceedings will determine whether the production base can be kept.

Construction at the Saemangeum lithium plant has no set restart date, and a KRW 19.7 billion impairment loss was recognized based on the third-quarter report.

The binding Head of Agreement with Prairie Lithium targets lithium intermediate supply and commercial production from a Canadian salt lake, but it is described as being at a very early stage, so the timing of any revenue contribution is hard to gauge.

On funding, the company raised about KRW 3 billion through on-market sales of treasury shares in the second half of 2025, and issued a series of small convertible bonds from the second to fifth tranches beginning December 2025, mostly between KRW 160 million and KRW 900 million.

Land at the Geumsan plant, the Gwangju headquarters and the Saemangeum site, with combined book value of KRW 29.7 billion, was included in the revaluation, which raises booked asset values but does not bring in cash.

Operating loss narrowed from the second quarter to the third quarter of 2026, so whether cost structure can sustain that trend in later quarters is the next checkpoint.

07

Valuation

PER
—
PBR
0.6×
ROE
-111.5%
EPS
-₩712
BPS
₩398
Dividend per share
₩0

The price-to-earnings ratio cannot be calculated because the last four quarters show net losses. The price-to-book ratio sits in a range below net asset value, and compared with an April 2026 data point that was above 1x, the premium over book value has narrowed.

Book equity includes real estate values lifted by the asset revaluation, so comparisons on a net asset basis need to account for that effect. The dividend yield is effectively zero, so shareholder return metrics do not apply.

Revenue-based multiples have limited meaning given the small revenue base, and linking valuation to business metrics requires watching whether operating losses narrow and how quickly revenue recovers. The operating margin was -447.1% in 2025, showing a wide loss gap.

The fact that the price-to-book ratio sits at a discount and the fact that the business remains loss-making should be read together rather than on one alone.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-14

08

Bull factors

Lithium price recovery

A July 2026 press report noted that lithium prices recovered more than twofold from their trough after a drop of close to 90% from the peak, helped by energy storage demand and supply adjustments. Because most of the company's revenue comes from lithium products, price recovery passes directly into results.

Prices still sit more than 70% below the peak, which also needs to be weighed. Further price gains could become the starting point for a revenue recovery.

Geumsan plant and industrial complex designation

The Geumsan plant is the core base producing lithium hydroxide and lithium carbonate, with designed capacity of about 3,600 tons. Its designation as part of the Geumsan lithium general industrial complex in 2025 raised attention on the site.

The Geumsan, Gwangju headquarters and Saemangeum sites, with combined book value of KRW 29.7 billion, are included in the revaluation. Dealsite reported that the asset value is expected to rise after revaluation given the Geumsan designation.

Narrower operating loss and new feedstock efforts

The operating loss narrowed to KRW 2.32 billion in Q3 2026 from KRW 3.45 billion in Q2 2026, and was also smaller than a year earlier. The binding Head of Agreement with Prairie Lithium is a new feedstock effort premised on lithium intermediate supply.

If it moves to commercial production, it could broaden the revenue base. The project is described as being at a very early stage.

09

Bear factors

Shrinking revenue base

Revenue in 2025 was KRW 3.37 billion, down 60.2% from 2024. Q3 2026 revenue was KRW 452 million, down 31.6% from a year earlier. The company attributed the decline mainly to the exclusion of its former construction business during the transition.

The bear case rests on the view that revenue recovery is hard without both sales volume and prices supporting lithium products.

Litigation and asset impairment burden

In the Geumsan plant ownership dispute, the first-instance court fully upheld the counterparty's claim around April 2026, ordering the cancellation of the transfer registration and delivery of movable assets. The Saemangeum plant has no set restart date, and a KRW 19.7 billion impairment was recognized. Both the core production base and the new business base are under pressure at the same time.

Liquidity and funding strain

Standalone cash equivalents were reported in the KRW 200 million range at the end of Q1 2026, and analysis noted that current liabilities exceeded current assets by about four times.

Convertible bonds in the second through fifth tranches have been issued in succession since December 2025, each between KRW 160 million and KRW 900 million. Operating cash flow was negative for four consecutive years from 2022 through 2025.

10

Risk factors

Litigation and governance

The ownership dispute over the Geumsan plant directly affects the production base. Shares held by a related party of the largest shareholder were reported to be subject to seizure and enforcement proceedings over unpaid taxes and debt defaults. The largest shareholder group's stake is recorded at 4.47%. Possible shifts in control could affect management continuity.

Liquidity and dilution

Convertible bonds have been issued in succession since December 2025, alongside a rights-related capital raise and treasury share sales. If the bonds convert into shares, the larger share count could dilute per-share value. The number of shares outstanding rose from the end of 2025 to the end of Q1 2026.

Industry and price volatility

Lithium prices remain more than 70% below their peak despite the recent recovery. Capacity additions led by Chinese producers keep price competition alive, and because revenue is concentrated in lithium products, the company bears price swings directly. In a downturn, operating losses could widen as they did in 2025.

11

What to watch next

  1. December 31, 2026

    The end of fiscal 2026. The Q4 operating result will be compared with the KRW 4.59 billion operating loss in Q4 2025 and will shape the full-year operating loss.

  2. March 31, 2027 (statutory deadline for the annual report)

    The 2026 annual report will confirm full-year revenue, operating result and net loss attributable to controlling shareholders, along with the status of the Geumsan litigation, any provisions and the valuation of the Saemangeum assets.

  3. May 15, 2027 (statutory deadline for the Q1 quarterly report)

    Q1 2027 revenue and operating result will be compared with the KRW 952 million revenue and KRW 3.37 billion operating loss in Q1 2026. Whether operating losses continue and how cash equivalents change are the checkpoints.

12

Overall view

Hydro Lithium's revenue has declined for two consecutive years since its 2023 peak, and it remains in a loss structure with operating and net losses continuing.

Q3 2026 showed an operating loss of KRW 2.32 billion and a net loss attributable to controlling shareholders of KRW 2.57 billion, and the last four quarters total KRW 40.1 billion in such losses.

Positive factors include the recovery in lithium prices from the trough, the Geumsan plant's industrial complex designation and designed capacity, and the narrowing of the operating loss from Q2 to Q3 2026.

On the other side, the first-instance loss in the Geumsan ownership dispute, the KRW 19.7 billion impairment at the Saemangeum plant, cash equivalents in the KRW 200 million range, and repeated small convertible bond issues weigh on business continuity.

Book equity of KRW 62.4 billion, lifted by the asset revaluation, shows the size of booked capital but does not indicate an improvement in cash flow.

Valuation can only be compared on a price-to-book basis while the business remains loss-making, and room for improvement on the business side depends on the direction of the operating margin. The next checkpoint is the operating result in the 2026 annual report and how the Geumsan litigation outcome is reflected.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 17 more articles and sources
  1. comp.fnguide.com
  2. comp.wisereport.co.kr
  3. newsworker.co.kr
  4. digitaltoday.co.kr
  5. dait90000.com
  6. m.news.nate.com
  7. news.nate.com
  8. dealsite.co.kr
  9. newstopkorea.com
  10. stockray.app
  11. cbci.co.kr
  12. tipranks.com
  13. alphadistill.com
  14. alphasquare.co.kr
  15. judal.co.kr
  16. catch.co.kr
  17. jobkorea.co.kr

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis